India  Video
> >

U.S. FDA approves biosimilar version of cancer drug Avastin

Reuters India Thursday, 14 September 2017
(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.
Share on
Share on
Post on 
Share by
Source: RTV6 The Indy Channel - < > Embed
News video: Drug tested to lessen chemo side effects at IU Health

▶ Drug tested to lessen chemo side effects at IU Health 01:39

With a $2.9 million grant, the IU Cancer Center has begun testing a new drug to lessen the side effects of chemotherapy. Doctors at the Simon Cancer Center are looking to develop the drug to help cancer patients.

You Might Like

Tweets about this

Other recent news in Health

NHS pay: INCREASE FOR 1.3 million staff expectedMISSISSIPPI's new law restricting abortion blocked by judge for 10 days
Piggie Park Enterprises Inc. Issues ALLERGY Alert on Undeclared Wheat and Soy in Maurice's Southern Gold Honey SauceBrazil to vaccinate entire country against YELLOW FEVER
Doctors endorse counseling of some kids, young adults to prevent SKIN CANCEROBESITY robs tongue of taste buds in mice, study finds
Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2018 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter